Cases 51 - 60 of 313
Teva Pharmaceuticals USA, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00007
Plaintiff:
Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd. and Teva Neuroscience, Inc.
Defendant:
Mylan Pharmaceuticals Inc. , Mylan Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2017cv00005
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 145
Sanofi-Aventis U.S. LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00024
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddys Laboratories, Ltd. et al
as 1:2016cv01267
Plaintiff:
Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd , Teva Neuroscience, Inc. and others
Defendant:
Doctor Reddys Laboratories, Ltd., Doctor Reddys Laboratories, Inc., Sandoz, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2016cv01114
Plaintiff:
Forest Laboratories, LLC , Forest Laboratories Holdings, Ltd. , Allergan USA, Inc. and others
Defendant:
Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. , Sandoz Inc. and others
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals U.S.A, Inc. v. Mylan Pharmaceuticals, Inc.
as 1:2016cv00202
Plaintiff:
Takeda Pharmaceuticals U.S.A, Inc.
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
as 1:2016cv00987
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Genzyme Corporation et al v. Mylan Laboratories Limited et al
as 1:2016cv00188
Plaintiff:
Genzyme Corporation , Southern Research Institute and Sanofi-Aventis U.S. LLC
Defendant:
Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 28 U.S.C. § 1338
Amgen Inc. v. Amneal Pharmaceuticals et al
as 1:2016cv00853
Defendant:
Aurobindo Pharma Ltd, Cadila Healthcare Ltd. doing business as Zydus Cadila, Hetero USA Inc. and others
Plaintiff:
Amgen Inc.
3Rd Party Defendant:
Alkem Laboratories Ltd. and Ascend Laboratories, LLC
Counter Claimant:
Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271
GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al
as 2:2016cv05828
Plaintiff:
GENZYME CORPORATION , SOUTHERN RESEARCH INSTITUTE and SANOFI-AVENTIS U.S. LLC.
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INC.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
